Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
8.50
-0.40 (-4.49%)
At close: Mar 3, 2026
-32.00%
Market Cap 1.02B
Revenue (ttm) 33.51M
Net Income (ttm) -29.57M
Shares Out 119.80M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 860,796
Average Volume 433,718
Open 9.10
Previous Close 8.90
Day's Range 8.30 - 9.10
52-Week Range 7.10 - 13.20
Beta 0.38
RSI 43.05
Earnings Date Jan 28, 2026

About Central Pharmaceuticals

Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It offers tablets, capsules, liquids, and ointment. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective vitamins & minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, anti-diabetic oral rehydration salt, antihistamines, antifungal, vitamins, antihyperglycemic, anti-diabetic, analgesics and antipyretic NSAID; and skin diseases, such as fungal and... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 75
Stock Exchange Dhaka Stock Exchange
Ticker Symbol CENTRALPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Central Pharmaceuticals's revenue was 33.06 million, an increase of 11.68% compared to the previous year's 29.60 million. Losses were -21.98 million, -48.18% less than in 2024.

Financial Statements

News

There is no news available yet.